ACCESSION: MSBNK-SMB_Measured-HSA015P0228000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 28
COMMENT: RAW_SPEC {'Blanc1-pos_10543': {'bp': 291636.0, 'sum': 947366.0}, 'Blanc1-pos_10417': {'bp': 282291.0, 'sum': 1042570.0}, 'EL03_pos_10076': {'bp': 278988.0, 'sum': 1084306.0}, 'EL08_pos_10079': {'bp': 254323.0, 'sum': 693742.0}, 'EL12_pos_10125': {'bp': 249023.0, 'sum': 707636.0}, 'EL07_pos_10079': {'bp': 244200.0, 'sum': 667844.0}, 'EL13_pos_10094': {'bp': 240962.0, 'sum': 659596.0}, 'EL02_pos_10167': {'bp': 238821.0, 'sum': 743506.0}, 'EL05_pos_10144': {'bp': 229885.0, 'sum': 694444.0}, 'EL01_pos_10067': {'bp': 228140.0, 'sum': 634774.0}, 'EL04_pos_10066': {'bp': 225624.0, 'sum': 653744.0}, 'EL21_pos_10103': {'bp': 225263.0, 'sum': 680434.0}, 'EL18_pos_10073': {'bp': 221955.0, 'sum': 605761.0}, 'EL11_pos_10072': {'bp': 215447.0, 'sum': 590115.0}, 'EL23_pos_10090': {'bp': 214955.0, 'sum': 640385.0}, 'EL19_pos_10161': {'bp': 212879.0, 'sum': 669965.0}, 'EL22_pos_10185': {'bp': 208521.0, 'sum': 685429.0}, 'EL10_pos_10066': {'bp': 206578.0, 'sum': 625144.0}, 'EL16_pos_10084': {'bp': 206305.0, 'sum': 611905.0}, 'EL24_pos_10072': {'bp': 202494.0, 'sum': 603635.0}, 'EL20_pos_10078': {'bp': 188785.0, 'sum': 608073.0}, 'EL09_pos_10084': {'bp': 184137.0, 'sum': 574392.0}, 'EL14_pos_10091': {'bp': 170509.0, 'sum': 530935.0}, 'EL06_pos_10109': {'bp': 162630.0, 'sum': 539485.0}, 'EL17_pos_10095': {'bp': 162126.0, 'sum': 559102.0}, 'EL15_pos_10108': {'bp': 160673.0, 'sum': 535555.0}, 'Blanc3-pos_10001': {'bp': 159614.0, 'sum': 521306.0}, 'Blanc2-pos_9987': {'bp': 158840.0, 'sum': 498604.0}}
COMMENT: RETENTION_TIME_STDEV 0.066
COMMENT: PRECURSOR_M/Z_RAW 228.232329
COMMENT: PRECURSOR_M/Z_STDEV 0.000057
COMMENT: PRECURSOR_IN_MS1 mz 228.232176; int 68.241; delta(ppm) 0.958893
COMMENT: PROPOSED_CHARGE_STATE +1; mz 229.235647; int 9.913; cor 0.846
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.066; C14H29NO; [M+H]+; delta(ppm) -0.066014
COMMENT: PROPOSED_MF MS-FINDER 3.262; C14H29NO; [M+H]+; delta(ppm) -0.065663
COMMENT: PROPOSED_MF SIRIUS5_Sirius 25.567; C14H29NO; [M+H]+; delta(ppm) -0.065663
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C14H29NO; [M+H]+; delta(ppm) -0.065663
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.902; C14H29NO; [M+H]+; delta(ppm) -0.065663
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.866; C12H27N4; [M+H]+; delta(ppm) 5.817256
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C14H29NO; [M+H]+; delta(ppm) -0.065663
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.977; JIOJLCAPGHFHDI-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCC(=O)NCC(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.970; FEQGPEABBFYLNO-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCC(=O)NCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.939; BDYUSDIJIDGWCY-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCC(=O)N(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.818; QEALYLRSRQDCRA-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCCCC(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.775; APIMNRBWCSRKIX-DWHHJUQANA-N; [M+H]+; CCCCCCCC\C=C/C[C@@H](O)[C@H](C)N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.271; KLWPMNOQFSPVII-DUXBJXIBNA-N; [M+H]+; Halaminol A;(+)-Halaminol A
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.216; APIMNRBWCSRKIX-DWHHJUQANA-N; [M+H]+; Halaminol C;(+)-Halaminol C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.172; JIOJLCAPGHFHDI-UHFFFAOYSA-N; [M+H]+; UNPD66438
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.167; BVWZJMSWYIKRNF-XCVDLUGHNA-N; [M+H]+; UNPD102995
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.131; RHSGKBXFWFDFGN-UHFFFAOYSA-N; [M+H]+; CNP0443379
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.100; FEQGPEABBFYLNO-UHFFFAOYSA-N; [M+H]+; N-ethyldodecanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.070; QEALYLRSRQDCRA-UHFFFAOYSA-N; [M+H]+; UNPD122086
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.035; BDYUSDIJIDGWCY-UHFFFAOYSA-N; [M+H]+; N,N-dimethyldodecanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.028; KHLSOOHKLMLAIT-UHFFFAOYSA-N; [M+H]+; 2-(2,2-dimethyl-4-pentyloxan-4-yl)ethan-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.028; NDWXIYYHLSYDIT-UHFFFAOYSA-N; [M+H]+; 2-[2,2-dimethyl-4-(3-methylbutyl)oxan-4-yl]ethan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BVWZJMSWYIKRNF-XCVDLUGHNA-N; [M+H]+; UNPD102995
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.983; KLWPMNOQFSPVII-DUXBJXIBNA-N; [M+H]+; Halaminol A;(+)-Halaminol A
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.978; APIMNRBWCSRKIX-DWHHJUQANA-N; [M+H]+; Halaminol C;(+)-Halaminol C
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.978; RHSGKBXFWFDFGN-UHFFFAOYSA-N; [M+H]+; CNP0443379
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.888; QEALYLRSRQDCRA-UHFFFAOYSA-N; [M+H]+; UNPD122086
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.880; JIOJLCAPGHFHDI-UHFFFAOYSA-N; [M+H]+; UNPD66438
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.864; BDYUSDIJIDGWCY-UHFFFAOYSA-N; [M+H]+; N,N-dimethyldodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.864; FEQGPEABBFYLNO-UHFFFAOYSA-N; [M+H]+; N-ethyldodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.688; KHLSOOHKLMLAIT-UHFFFAOYSA-N; [M+H]+; 2-(2,2-dimethyl-4-pentyloxan-4-yl)ethan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.688; NDWXIYYHLSYDIT-UHFFFAOYSA-N; [M+H]+; 2-[2,2-dimethyl-4-(3-methylbutyl)oxan-4-yl]ethan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.993; QEALYLRSRQDCRA-UHFFFAOYSA-N; [M+H]+; tetradecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.366; BDYUSDIJIDGWCY-UHFFFAOYSA-N; [M+H]+; N,N-dimethyldodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.657; MDYPFOFSXHBHFE-UHFFFAOYSA-N; [M+H]+; N-dodecylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.636; CYMHAQCMKNVHPA-UHFFFAOYSA-N; [M+H]+; 3-butyl-2-heptan-3-yl-1,3-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.247; JFUCOPIALLYRGN-UHFFFAOYSA-N; [M+H]+; N,N-dihexylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; VEQUOQRRYHGBHZ-UHFFFAOYSA-N; [M+H]+; 2-butyl-3-(dimethylamino)-2-ethyl-4,4-dimethylcyclobutan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; VXOHMBHHIUTXKU-UHFFFAOYSA-N; [M+H]+; N,N,2-tripropylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; KKUPUFSKTUODSJ-UHFFFAOYSA-N; [M+H]+; N,N-di(propan-2-yl)-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.771; AUUQQEYJIBJJDU-UHFFFAOYSA-N; [M+H]+; 6-(azepan-1-yl)-2-methylheptan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.402; SSBCFULQQBTATN-UHFFFAOYSA-N; [M+H]+; 4-(4-propylheptan-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -40.850; FEQGPEABBFYLNO; [M+H]+; N-ethyldodecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -52.792; JIOJLCAPGHFHDI; [M+H]+; N-isobutyl-decanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -57.554; QEALYLRSRQDCRA; [M+H]+; Myristamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -69.622; MDYPFOFSXHBHFE; [M+H]+; N-Laurylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -103.002; JPDCAAMJJHFYPK; [M+H]+; 1-Aminotetradecanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -120.880; VUTLSSQIPUZBKI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.196; OOYRLFIIUVBZSY; [M+H]+; Decanamide,N-diethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -150.031; BDYUSDIJIDGWCY; [M+H]+; Hallcomid M 12
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.210; KAXVRMIUQJXONY; [M+H]+; 4-Decylmorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.927; KLWPMNOQFSPVII; [M+H]+; Halaminol A
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.040; JFUCOPIALLYRGN; [M+H]+; n,n-dihexylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.575; APIMNRBWCSRKIX; [M+H]+; Halaminol C
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.642; TUZDHGXGZZMZQV; [M+H]+; 2-sec-Butyl-N-isopropyl-2,3-dimethylpentanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.733; BVWZJMSWYIKRNF; [M+H]+; (E,2S,3R)-2-aminotetradec-11-en-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.589; KKUPUFSKTUODSJ; [M+H]+; N,N-Diisopropyl-2-propylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.292; NDWXIYYHLSYDIT; [M+H]+; 2-[2,2-dimethyl-4-(3-methylbutyl)oxan-4-yl]ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.358; NJYRBFYAWUYSIJ; [M+H]+; N,2-Di-sec-butyl-3-methylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -216.144; KHLSOOHKLMLAIT; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.162; VXOHMBHHIUTXKU; [M+H]+; N,N,2-Tripropylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.114; CYMHAQCMKNVHPA; [M+H]+; 3-Butyl-2-(1-ethylpentyl)oxazolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.742; VEQUOQRRYHGBHZ; [M+H]+; 2-Butyl-3-(dimethylamino)-4,4-dimethyl-2-ethylcyclobutanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.438; FEQGPEABBFYLNO; [M+H]+; N-ethyldodecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -176.254; MDYPFOFSXHBHFE; [M+H]+; N-dodecylethanimidate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -194.644; VNLRYCURXUALAI; [M+H]+; N-decylbutanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -203.112; JFUCOPIALLYRGN; [M+H]+; n,n-Dihexylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.288; VUTLSSQIPUZBKI; [M+H]+; (3S)-3-tridecyloxaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -223.849; KAXVRMIUQJXONY; [M+H]+; 4-Decylmorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -226.721; JIOJLCAPGHFHDI; [M+H]+; Tetrahydropellitorine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -238.257; FEQGPEABBFYLNO; [M+H]+; N-ethyldodecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -238.779; QEALYLRSRQDCRA; [M+H]+; Myristamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -249.151; JPDCAAMJJHFYPK; [M+H]+; 1-Aminotetradecanone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -276.562; BDYUSDIJIDGWCY; [M+H]+; N,N-Dimethyldodecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.315; MDYPFOFSXHBHFE; [M+H]+; N-dodecylethanimidate
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C14H30N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.455
MS$FOCUSED_ION: PRECURSOR_M/Z 228.232176
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004i-3190000000-00c56f126d33f6bf63e0
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0544726 42.8405 55.055180 1.2170 11.17 0.5391 26 f{C4H7}/4.47ppm,p-C10H23N1O1
  57.0701299 144.1929 57.070846 0.3855 19.59 0.8139 28 f{C4H9}/4.44ppm,p-C10H21N1O1
  58.0734293 12.5987 58.074150 1.1709 3.19 0.1391 24 ?
  60.0445709 27.7213 60.045298 0.8827 51.07 0.7508 25 f{C2H6N1O1}/3.01ppm,p-C12H24
  67.0543529 37.2308 67.055094 1.0290 7.18 0.5330 27 f{C5H7}/1.88ppm,p-C9H23N1O1
  69.0699714 42.3341 69.070714 1.3030 15.02 0.4128 27 f{C5H9}/1.37ppm,p-C9H21N1O1
  71.0492280 17.9797 71.049971 1.2949 5.14 0.1270 24 f{C4H7O1}/1.22ppm,p-C10H23N1
  71.0856325 38.3447 71.086376 0.7174 8.85 0.6464 28 f{C5H11}/1.49ppm,p-C9H19N1O1
  74.0601447 33.0215 74.060886 0.9587 7.53 0.3992 25 f{C3H8N1O1}/1.41ppm,p-C11H22
  81.0698907 40.7354 81.070617 0.9375 11.44 0.3038 28 f{C6H9}/0.17ppm,p-C8H21N1O1
  83.0855385 31.8464 83.086258 1.2517 8.37 0.1253 28 f{C6H11}/0.14ppm,p-C8H19N1O1
  85.1012064 14.2595 85.101917 1.3278 5.07 0.3493 28 f{C6H13}/0.35ppm,p-C8H17N1O1
  88.0757099 116.4217 88.076407 0.5677 26.24 0.4371 27 f{C4H10N1O1}/0.22ppm,p-C10H20
  93.0698509 19.3347 93.070518 1.0530 11.35 0.1854 25 f{C7H9}/-0.28ppm,p-C7H21N1O1
  95.0855380 63.4395 95.086190 0.9675 16.13 -0.0471 28 f{C7H11}/0.12ppm,p-C7H19N1O1
  97.1011388 17.1148 97.101776 1.1740 7.09 0.2174 23 f{C7H13}/-0.39ppm,p-C7H17N1O1
  102.0913577 66.5365 102.091951 0.7053 12.23 0.3858 27 f{C5H12N1O1}/0.17ppm,p-C9H18
  109.1011596 31.0128 109.101688 1.0082 8.52 0.0203 28 f{C8H13}/-0.16ppm,p-C6H17N1O1
  116.1070008 26.1573 116.107475 1.0163 5.26 0.5435 24 f{C6H14N1O1}/0.09ppm,p-C8H16
  134.0964251 71.0025 134.096711 0.8949 13.24 0.4209 28 f{C9H12N1}/-0.01ppm,p-C5H18O1
  135.0999188 68.1440 135.100192 1.1473 11.42 0.6027 28 ?
  175.1482694 19.4013 175.148642 1.5358 4.69 0.4165 24 f{C13H19}/0.81ppm,p-C1H11N1O1
  226.1589131 68.0243 226.159292 1.0789 17.52 0.2095 22 ?
  227.1622765 495.5800 227.162652 0.3874 74.14 0.5961 28 ?
  228.2321765 999.0000 228.232548 0.3111 0.00 1.0000 28 f{C14H30N1O1}/-0.06ppm,p
  228.2688892 33.8027 228.269261 0.8411 5.18 0.6062 25 ?
  229.1404108 49.0539 229.140780 1.4358 12.36 0.2585 21 ?
  229.2355478 109.5021 229.235916 0.8463 7.54 0.9250 28 ?
PK$NUM_PEAK: 28
PK$PEAK: m/z int. rel.int.
  55.054473 42.84 42
  57.070130 144.19 144
  58.073429 12.60 12
  60.044571 27.72 27
  67.054353 37.23 37
  69.069971 42.33 42
  71.049228 17.98 17
  71.085632 38.34 38
  74.060145 33.02 33
  81.069891 40.74 40
  83.085539 31.85 31
  85.101206 14.26 14
  88.075710 116.42 116
  93.069851 19.33 19
  95.085538 63.44 63
  97.101139 17.11 17
  102.091358 66.54 66
  109.101160 31.01 31
  116.107001 26.16 26
  134.096425 71.00 71
  135.099919 68.14 68
  175.148269 19.40 19
  226.158913 68.02 68
  227.162276 495.58 495
  228.232176 999.00 999
  228.268889 33.80 33
  229.140411 49.05 49
  229.235548 109.50 109
//
